CITES and Others Invest US$2.7m in Biotech Eolo Pharma (en español) December 31, 2019 Uruguay-based biotech Eolo Pharma raised a US$2.7m Series A from CITES and a group of international investors to fund preclinical trials for an obesity treatment. Eolo Pharma is run by…